Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Facioscapulohumeral Muscular Dystrophy (FSHD), confirmed by a genetic test
- You are between 18 and 50 years old
- Your FSHD has been classified into a specific group that includes the most typical signs of the disease, such as weakness in the face and shoulder muscles (confirm with trial site)
- Your condition falls within a certain range on a clinical scoring system, scored between 2 and 5 (confirm with trial site)
- You are still able to walk at the time of joining the trial
- You have no problems affecting your brain or nerves, based on your medical history and a physical check-up
- You do not have a curved spine (scoliosis), tightening of the joints in your limbs, or shortened tendons
Who may not be able to join:
- You are currently taking beta-blocker medications (a type of heart or blood pressure medicine)
- You have a psychological or psychiatric condition
- You have a muscle or joint injury that stops you from doing physical exercise
- You have recently changed your medications, or you take drugs that affect tiredness or wakefulness (such as Modafinil or amantadine)
- You are currently taking part in another clinical trial, or finished one less than 30 days ago
- You are pregnant or breastfeeding
- You are not able to fully understand the study or give your consent to take part
- You have other health conditions that could affect the study's measurements
- You are under legal guardianship or do not have full legal freedom (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0383 62053
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in fat mass in FSHD; Change in fat-free mass in FSHD; Change in aerobic capacity in FSHD; Change in muscle strength in FSHD; Change in walking performance in FSHD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.